Animol
Boston, US · Founded 2018 · 3 known investors
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.
Founders & leadership
Animol was founded in 2018 by Andrew Calabrese.
AC
Andrew CalabreseScientific Co-Founder
PA
Philip AustinCo-founder (Managing Partner, Anterra Capital)
AP
Andrew PlantNamed on SEC filing
DE
Douglas E. HutchensCSO
LA
Logan AndrewsHead of Program Management
Board
MD
MH
Michelle HavenBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$36M disclosed across 2 rounds · 2022–2024
▶$4MraisedDec 2024 · 1 investors · OtherRule 506(b)
▶$4MraisedDec 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Marijn DekkersDirector
- Michelle HavenDirector
- Philip AustinExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32MraisedAug 2022 · 3 investors · OtherRule 506(b)
▶$32MraisedAug 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michelle HavenDirector
- Philip AustinExecutive Officer, Director
- Andrew PlantExecutive Officer, Director
- Marijn DekkersDirector
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapAnivive Lifesciences3 shared keywordsAnivive develops new medicines for companion animals, using software across the drug development process to accelerate the creation of treatments. It serves the animal health community, focusing on veterinary and pet health pharmaceuticals.
Examol3 shared keywordsCloud infrastructure for computational chemistry.
Companies competing with Animol for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Animol do?
- Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases. It uses a technology platform to discover active pharmaceutical ingredients designed for veterinary patients.
- Who founded Animol?
- Animol was founded by Andrew Calabrese in 2018.
- Who are Animol's investors?
- Animol's investors include Novalis LifeSciences, Anterra Capital, DYDX Capital.
- How much funding has Animol raised?
- Animol has disclosed $36M raised across 2 rounds.
- Where is Animol headquartered?
- Animol is headquartered in Boston, US.